These data raise the possibilty that clenbuterol treatment suppressed inflammatory mediators IL-1β and TNF-α by promoting alternative microglia activation and exerting neuroprotective effects in sepsis-induced cognitive impairments, although we cannot exclude its possible peripheral anti-inflammatory effects. The gene discussed is IL1B; the disease is Sepsis.